$ESPR: Esperion Announces Late-Breaking Oral Presentation of Final Study …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR), today announced that the final Phase 3 results from Study 3 (1002-046, also known as CLEAR …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675551/esperion-announces-late-breaking-oral-presentation-of-final-study-3-re

Related News:

$ALG $ESPR $KANG: Hedge Funds Aren’t Showing Much Interest in Alamo Group, Inc. (ALG)

$PXD $ESPR $PCTY: Report: Exploring Fundamental Drivers Behind American Vanguard …

$ESPR: Esperion Announces Positive Top-Line Results from Final Pivotal …

$ESPR: Esperion Announces Completion of Phase 3 LDL-C Lowering …

$ESPR: Esperion up 8% premarket

$LMAT $CVS $ESPR: 3 Top Healthcare Stocks to Buy in October

$ESPR: Esperion Announces Inducement Grants Under NASDAQ Listing …

$ESPR: Esperion Announces Inducement Grants Under NASDAQ Listing …

Latest News:

$OXY: Here’s What Investors Can Expect From Oil Prices in 2019

$GD: General Dynamics Bags a $1.2 Billion Deal for Abrams M1 Tanks

$INAP $KOS: 5 Stocks Priced Under $10 With Massive Implied Upside Potential

$0753.HK $BA: Boeing Flies Close to Trade Tussle With New Facility in China

$BIIB: Better Buy: Biogen vs. Amgen

$NOC: Northrop Grumman: Price Is Lower Despite Less Risks

$BTE $KLIC: Should You Buy Baytex Energy Corp (BTE)?

$FICO $GOLD: Fair Isaac Corporation (FICO): Are Hedge Funds Right About This …

$UTHR: MannKind – Afrezza Scripts Hit Milestone As 2018 Comes To A Close

$JLL: Should You Buy Jones Lang LaSalle Inc (JLL)?

$INGN $OSK: Hedge Funds Are Crazy About Inogen Inc (INGN)